• Long lead time for salt structure screening and crystal structure screening
• Insufficient depth in the development and optimization of analytical methods, resulting in repeated efforts.
• Challenges in quickly identifying an optimal API purification method during process optimization.
• Delays in impurity studies, preventing rapid method validation.
• Inadequate coverage of impurities in the safety assessment batch.